Clinical Trial Update: Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating naloxegol for treating stage IIIB/IV non-small cell lung cancer has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Naloxegol (naloxegol)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2022-08-03